Antinociceptive properties of FR140423 mediated through spinal δ-, but not μ- and κ-, opioid receptors

European Journal of Pharmacology

Volumn 380, Issue 2-3, 1999, Pages 73-79

  Ochi, Takehiro ^a   Fujii, Takashi ^a   Motoyama, Yukio ^a   Goto, Toshio ^a  

^a Med Chemistry Research Laboratories   (Japan)

Author keywords

Antinociception; FR140423; Mice; Opioid; Spinal cord

Indexed keywords

3 (DIFLUOROMETHYL) 1 (4 METHOXYPHENYL) 5 [4 (METHYLSULFINYL)PHENYL]PYRAZOLE; BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALOXONAZINE; NALOXONE; NALTRINDOLE; NARCOTIC ANALGESIC AGENT; NORBINALTORPHIMINE; OPIATE ANTAGONIST; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ADMINISTRATION, ORAL; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; DIARRHEA; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MEMBRANES; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; PYRAZOLES; RATS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SPINAL CORD; SULFOXIDES;

EID: 0032837168     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00522-1     Document Type: Article

References (21)

1. Cashman J.N. The mechanisms of action of NSAIDs in analgesia. Drugs. 52:1996;13-23. Suppl. 5.
2. Chen J., Smith E.R., Cahill M., Cohen R., Fishman J.B. The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine. Life Sci. 52:1993;389-396.
3. Ferreira S.H., Lorenzetti B.B., Devissaguet M., Lesieur D., Tsouderos Y. S14080, a peripheral analgesic acting by release of an endogenous circulating opioid-like substance. Br. J. Pharmacol. 114:1995;303-308.
4. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
5. Hoskin P.J., Hanks G.W. Opioid agonist-antagonist drugs in acute and chronic pain states. Drugs. 41:1991;326-344.
6. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
7. Kamei C., Shimomura K., Ueki S. Significance of withdrawal jumping response in predicting physical dependence in mice. Jpn. J. Pharmacol. 23:1973;421-426.
8. Ling G.S.F., MacLeod J.M., Lee S., Lockhart S.H., Pasternak G.W. Separation of morphine analgesia from physical dependence. Science. 226:1984;462-464.
9. Ling G.S.F., Simantov R., Clark J.A., Pasternak G.W. Naloxonazine actions in vivo. Eur. J. Pharmacol. 129:1986;33-38.
10. Litchfield J.T. Jr., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
11. Miyamoto Y., Takemori A.E. Relative involvement of supraspinal and spinal μ opioid receptors in morphine dependence in mice. Life Sci. 52:1993;1039-1044.
12. Ochi, T., Fujii, T., Motoyama, Y., Goto, T., 1999a. The profile of FR140423, a novel anti-inflammatory compound, in yeast-induced rat hyperalgesia. Jpn. J. Pharmacol., in press.
13. Ochi T., Jobo-Magari K., Yonezawa A., Matsumori K., Fujii T. Anti-inflammatory and analgesic effects of a novel pyrazole derivative, FR140423. Eur. J. Pharmacol. 365:1999;259-266.
14. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16:1993;1-18.
15. Rang H.P., Urban L. New molecules in analgesia. Br. J. Anaesth. 75:1995;145-156.
16. Shimomura K., Kamata O., Ueki S., Ida S., Oguri K., Yoshimura H., Tsukamoto H. Analgesic effect of morphine glucuronides. Tohoku J. Exp. Med. 105:1971;45-52.
17. Takagi H., Inukai T., Nakama M. A modification of Haffner's method for testing analgesics. Jpn. J. Pharmacol. 16:1966;287-294.
18. Tsuji K., Konishi N., Spears G.W., Ogino T., Nakamura K., Tojo T., Ochi T., Shimojo F., Senoh H., Matsuo M. Studies on anti-inflammatory agents. V. Synthesis and pharmacological properties of 3-(difuoromethyl)-1-(4-methoxyphenyl)-5-[4-(methylsulfinyl)phenyl]pyrazole and related compounds. Chem. Pharm. Bull. 45:1997;1475-1481.
19. Yaksh T.L., Kohl R.L., Rudy T.A. Induction of tolerance and withdrawal in rats receiving morphine in the spinal subarachnoid space. Eur. J. Pharmacol. 42:1977;275-284.
20. Zadina J.E., Hackler L., Ge L., Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature. 386:1997;499-502.
21. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.